24小时热门版块排行榜

返回列表

当前只显示满足指定条件的回帖，点击这里查看本话题的所有回帖

zlwcw

木虫 (著名写手)

应助: 1 (幼儿园)
金币: 2021.1
散金: 225
红花: 8
帖子: 1274
在线: 219.7小时
虫号: 530429
注册: 2008-03-21
性别: GG
专业: 代谢性疾病药物药理

[交流] 【其他】药明康德伟业蓬勃发展已有25人参与

按照公司大楼启用的先后顺序编号，位于外高桥保税区德林路90号已经竣工的两幢大楼被编为药明康德12#和13#大楼，

日期已经陆续搬入启用。以下是12#和13#大楼的现场照片。

药明康德伟业蓬勃发展，让我们高歌猛进，用智慧和勤劳的双手，筑起更加雄伟的药明康德大厦。

Ground Breaking Ceremony of WuXi AppTec Biopharmaceuticals Co., Ltd.

Successfully Held in WuXi

On June 11, The ground breaking ceremony of WuXi AppTec Biophamaceuticals Co., Ltd. was successfully held in the city of WuXi. Mr. Yang Weize, Member of the Standing Committee of Jiangsu Provincial CPC Committee and Secretary of WuXi Municipal CPC Committee, Mr. Mao Xiaoping, Mayor of WuXi, Mr. Gong Peixing, chairman of WuXi City's Political Consultative Conference, and government officials from related departments, together with the delegation led by Dr. Ge Li, chairman of CEO of WuXi AppTec, attended the ceremony.

WuXi AppTec Biopharmaceuticals Co., Ltd., a wholly-owned subsidiary of WuXi AppTec, is a new biotechnology R&D and manufacturing services outsourcing company. With a registered investment of 15 million US dollars and a facility area of 67,000 square meters, the new company aims at building up a world-class biopharmaceutical outsourcing service base with the most advanced technology and compliance with the standards of FDA, to provide monoclonal antibody, vaccine, protein recombinant related “one-stop” R&D services to global biotech companies.

Ni Bin, assistant to WuXi mayor addressed that WuXi and Binhu government will give preferential policy and environmental support to WuXi AppTec to leverage its talents, company brand and international influence in order to build a new company in Binhu. Taking the advantages of the parent company’s cutting-edge technology and research scientists in biologics, the new company will provide global biotech companies with new biotech R&D services and the research and manufacturing services for generic drugs in the biotechnology industry as well.

Zhu Weiping, Secretary of BinHu District CPC Committee said that the establishment of WuXi AppTec Biopharmaceuticals Co., Ltd., will definitely attract a large quantity of elite talents, leading groups and institutions to the city of WuXi, bring investment from key enterprises and promote the development of WuXi biotechnology industry.

Dr. Ge Li expressed his gratitude to the recognition and support from WuXi government. “Over 4200 employees of WuXi AppTec will make more efforts and contributions, to support the development of WuXi Bio-pharmaceutical R&D Outsourcing Service Park”, commented Dr. Li.

无锡药明康德生物技术有限公司奠基仪式成功举行

2010年6月11日，无锡药明康德生物技术有限公司奠基仪式在无锡生物医药研发服务外包区成功举行。省委常委、无锡市委书记杨卫泽、无锡市人民政府市长毛小平、无锡市政协主席贡培兴等市区领导、度假区领导和药明康德董事长兼首席执行官李革博士带领的药明康德代表团成员参加了奠基仪式。

无锡药明康德生物技术有限公司是药明康德新药开发有限公司投资建立的生物药物研发和生产服务外包项目，该项目注册资本1亿元，占地100亩，将采用美国公司专有技术和人才，按照FDA等国际先进标准建设一流的生物药物外包服务基地。建成后能为全球生物制药公司提供单克隆抗体、疫苗、重组蛋白等生物药物“一站式”的研发和生产外包服务。

无锡市人民政府市长助理倪斌表示，无锡市领导及滨湖区政府，将在政策扶持和经营环境上积极支持药明康德发挥人才、品牌的优势，利用药明康德的国际影响力，利用药明康德拥有的生物领先技术和研发团队，面向国内外生物医药企业提供新型生物药研发服务，并涉足生物仿制药行业的研发和生产服务。

无锡市滨湖区区委书记朱渭平表示，这一举措，同时也必将吸引一批海内外顶尖人才、领军团队和机构到无锡，吸引关键企业到无锡投资，推动无锡生物医药产业的发展。

李革博士在奠基仪式上，对无锡市各级政府对药明康德的认可和支持表达了感谢，并表示药明康德的全体员工将以更大的努力，支持无锡马山生物医药产业基地的发展。